USMV240920C81000
- 6.48
- 0.000.00%
iShares MSCI Min Vol USA ETF Newsroom
Futu Morning News | Rate cut countdown! US stocks continue to break records; Bank of America: Long the seven giants of US stocks is still the most crowded trade.
"New美联储通讯社": The situation is complex, and there are still doubts about the magnitude of the Fed's first rate cut; if the Fed's first cut is done "properly", the record-breaking betting on a significant rate cut may face huge risks; Apple's iPhone 16 series pre-order sales in the first weekend fell short of expectations, analysts: the long-term outlook remains optimistic.
Looking Into Eli Lilly's Recent Short Interest
Kroger, Albertsons Shares Dip After FTC Gives Closing Arguments In Hearing To Block Merger
Christmas Is Coming Early This Year, as Retailers Face Economic Worries, Late Thanksgiving
Walmart Division Sam's Club Raises Wages For Hourly Associates: A Strategic Move To Stay Ahead In Retail
Watching Shares Of Auto Insurance Companies; Donald Trump Post On X, "Your Automobile Insurance Is up 73% — VOTE FOR TRUMP, I'LL CUT THAT NUMBER IN HALF!"
10 Information Technology Stocks With Whale Alerts In Today's Session
Rhythm Pharma Draws Bullish View at JMP on Opportunity in Rare Genetic Obesities
13 ETFs To Own As Fed Set To Cut Rates: Analysts Highlight Utilities, Real Estate, And More
Evaluating Walmart Against Peers In Consumer Staples Distribution & Retail Industry
Retail sales drive US stocks higher! The S&P 500 Index and the Dow Jones Industrial Average hit record highs intraday, and Chinese assets are surging across the board.
China's assets are exploding.
Unpacking the Latest Options Trading Trends in Eli Lilly
BTIG Waves the Caution Flag Around the Consumer Staples Sector
Wedbush Spotlights DELL, NVDA, MSFT, and Others as Rate Cuts Should Support the AI Trend
Preview of US stocks | August retail sales data exceeds expectations, three major futures indices slightly rise; Bullish news frequently! Intel pre-market up nearly 7%.
Microsoft is giving out "red envelopes": dividend increase of 10%, planning to repurchase up to 60 billion US dollars; "New Fed Communication Agency" reiterated uncertainty: the magnitude of the first interest rate cut is still suspenseful.
Major breakthrough in cancer treatment? Pharmaceutical companies invest billions of dollars, competing to bet on targeted radiation therapy.
Radioactive drugs have the potential to become a significant breakthrough in cancer treatment. In the past year, global pharmaceutical giants such as bristol-myers squibb, astrazeneca, and eli lilly and co have invested approximately 10 billion US dollars to actively enter the field of radioactive drugs through acquisitions and collaborations, aiming to replicate the success of Novartis in the drugs Lutathera and Pluvicto. Currently, these radioactive drugs are mainly used to treat certain types of neuroendocrine tumors and prostate cancer, with the potential to expand to the treatment of more types of cancer in the future.
Walmart Unusual Options Activity For September 16
10 Information Technology Stocks Whale Activity In Today's Session
Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $885 Price Target
Eli Lilly Analyst Ratings